CSIMarket
 

West Pharmaceutical Services Inc   (NYSE: WST)

West Pharmaceutical Services Inc 's

Competitiveness




 

WST Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, West Pharmaceutical Services Inc reported Revenue increase in the 2 quarter 2026 by 13.89 % year on year.
The sales growth was above West Pharmaceutical Services Inc 's competitors' average revenue growth of 10.18 %, achieved in the same quarter.

List of WST Competitors

With a net margin of 17.65 % West Pharmaceutical Services Inc achieved higher profitability than its competitors.

More on WST Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


West Pharmaceutical Services Inc Net Income in the 2 quarter 2026 grew year on year by 16.84%, slower than its competitors' income growth of 31.28 %

<<  WST Stock Performance Comparisons


West Pharmaceutical Services Inc 's Comment on Competition and Industry Peers


We compete with several companies across our Proprietary Products product lines. Due to the special nature of our pharmaceutical packaging components and our long-standing participation in the market, competition for these components is based primarily on product design and performance, although total cost is becoming increasingly important as pharmaceutical companies continue with aggressive cost-control programs across their operations.

In addition, there is a small number of competitors supplying medical devices and medical device components. We compete in this market on the basis of our reputation for quality and reliability in engineering and project management, as well as our knowledge of, and experience in, compliance with regulatory requirements.

We also have specialized knowledge of container closure components, which is integral to developing delivery systems. With our range of proprietary technologies, we compete with new and established companies in the area of drug delivery devices, including suppliers of prefillable syringes, auto-injectors, safety needles and other proprietary systems.

We differentiate ourselves from our competition by being an integrated drug containment and delivery systems global supplier that can provide pre-approval primary packaging support and engineering development, analytical services, regulatory expertise and after-sale technical support. Customers also appreciate the global scope of our manufacturing capability and our ability to produce many products at multiple sites.

Our Contract-Manufactured Products business operates in very competitive markets for its products. The competition varies from smaller regional companies to large global molders. Given the cost pressures they face, many of our customers look off-shore to reduce cost. We differentiate ourselves by leveraging our global capability and by employing new technologies such as high-speed automated assembly, insert-molding, multi-shot molding and expertise with multiple-piece closure systems.





  

Overall company Market Share Q2 2026

West Pharmaceutical Services Inc achieved revenue growth of 13.89 % in Overall company, and improved market share, to approximately 2.27 %.


<<  More on WST Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of West Pharmaceutical Services Inc




Alcon inc
Share Performance



-9.15%
This Year



Alcon inc
Profile

Alcon Inc's business model revolves around providing advanced eye care products and services, including pharmaceuticals, surgical equipment, and vision care solutions.

More about Alcon inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 34,982.100 mill. $ 12,997.000 mill. $ 1,156.000 mill.


Danaher Corporation
Share Performance



+16.61%
This Quarter



Danaher Corporation
Profile

Danaher Corporation operates a diversified business model centered on developing advanced technologies and solutions across multiple sectors, particularly life sciences, diagnostics, dental, and environmental. The company emphasizes continuous innovation and operational excellence, leveraging its proprietary technologies to drive growth and improve efficiency. By strategically acquiring and integrating complementary businesses, Danaher enhances its product offerings while expanding its global market presence.

More about Danaher Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 146,940.216 mill. $ 25,107.000 mill. $ 4,004.000 mill.


National Vision Holdings Inc
Share Performance



-3.68%
Over The Past 5 Days



National Vision Holdings Inc
Profile

National Vision Holdings Inc is a leading retailer of eyewear and optical products in the United States. The company operates a vertically integrated business model, which involves manufacturing, marketing, and distributing a wide range of eyewear products through its branded retail stores and third-party retail locations. National Vision Holdings Inc focuses on offering affordable and accessible vision care solutions to customers by leveraging its supply chain and retail network capabilities.

More about National Vision Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,349.194 mill. $ 2,033.426 mill. $ 50.286 mill.


Icu Medical Inc
Share Performance



-4.29%
Over The Past 5 Days



Icu Medical Inc
Profile

ICU Medical Inc's business model focuses on the development, manufacture, and sale of innovative medical devices and solutions for critical care settings.

More about Icu Medical Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,196.874 mill. $ 2,159.998 mill. $ 30.089 mill.


Koru Medical Systems Inc
Share Performance



-17.09%
This Quarter



Koru Medical Systems Inc
Profile

Koru Medical Systems Inc has a business model centered around providing medical solutions or services.

More about Koru Medical Systems Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 150.686 mill. $ 43.257 mill. $ -2.279 mill.

16 more competitors available

Sign in to see all competitors

Sources: West Pharmaceutical Services Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on West Pharmaceutical Services Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.